Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Marcel

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cell Death & Disease|February 16, 2013
A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effectsC Sagne, V Marcel, A Amadou, et al.
Genetics|February 7, 1998
Variation of dominance of newly arisen adaptive genesD Bourguet, T Lenormand, T Guillemaud, et al.
Cancer Gene Therapy|October 23, 2010
Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapiesI Goldstein, V Marcel, M Olivier, et al.
FEBS Letters|December 23, 1998
A putative kinetic model for substrate metabolisation by Drosophila acetylcholinesteraseJ Stojan, V Marcel, S Estrada-Mondaca, et al.
The Journal of Biological Chemistry|April 15, 2000
Exploration of the Drosophila acetylcholinesterase substrate activation site using a reversible inhibitor (Triton X-100) and mutated enzymesV Marcel, S Estrada-Mondaca, F Magné, et al.
Oncogene|March 2, 2010
p53 regulates the transcription of its Delta133p53 isoform through specific response elements contained within the TP53 P2 internal promoterV Marcel, V Vijayakumar, L Fernández-Cuesta, et al.
Cancer Gene Therapy|September 20, 2008
Recent advances in p53 research: an interdisciplinary perspectiveM Olivier, A Petitjean, V Marcel, et al.
Journal of Medical Genetics|June 23, 2009
TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosisV Marcel, E I Palmero, P Falagan-Lotsch, et al.
Cell Death and Differentiation|November 15, 2011
Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activityV Marcel, I Petit, F Murray-Zmijewski, et al.
Cell Death and Differentiation|September 24, 2011
Biological functions of p53 isoforms through evolution: lessons from animal and cellular modelsV Marcel, M-L Dichtel-Danjoy, C Sagne, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cell Death & Disease|February 16, 2013
A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effectsC Sagne, V Marcel, A Amadou, et al.
Genetics|February 7, 1998
Variation of dominance of newly arisen adaptive genesD Bourguet, T Lenormand, T Guillemaud, et al.
Cancer Gene Therapy|October 23, 2010
Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapiesI Goldstein, V Marcel, M Olivier, et al.
FEBS Letters|December 23, 1998
A putative kinetic model for substrate metabolisation by Drosophila acetylcholinesteraseJ Stojan, V Marcel, S Estrada-Mondaca, et al.
The Journal of Biological Chemistry|April 15, 2000
Exploration of the Drosophila acetylcholinesterase substrate activation site using a reversible inhibitor (Triton X-100) and mutated enzymesV Marcel, S Estrada-Mondaca, F Magné, et al.
Oncogene|March 2, 2010
p53 regulates the transcription of its Delta133p53 isoform through specific response elements contained within the TP53 P2 internal promoterV Marcel, V Vijayakumar, L Fernández-Cuesta, et al.
Cancer Gene Therapy|September 20, 2008
Recent advances in p53 research: an interdisciplinary perspectiveM Olivier, A Petitjean, V Marcel, et al.
Journal of Medical Genetics|June 23, 2009
TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosisV Marcel, E I Palmero, P Falagan-Lotsch, et al.
Cell Death and Differentiation|November 15, 2011
Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activityV Marcel, I Petit, F Murray-Zmijewski, et al.
Cell Death and Differentiation|September 24, 2011
Biological functions of p53 isoforms through evolution: lessons from animal and cellular modelsV Marcel, M-L Dichtel-Danjoy, C Sagne, et al.
Pageof 2